Peptide record

TPDB10463

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10463
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FVGPVLKIAAGILPTAICKIYKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C121H204N28O27S2
RNDEQHMSW
IK
2547.24
9.98
4
0
13
+4
-1.06
1.067
134.17
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
1615
0.63
4
Residue Composition
number
3
A
0
R
0
N
0
D
2
C
0
E
0
Q
2
G
0
H
4
I
2
L
4
K
0
M
1
F
2
P
0
S
1
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 3 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 4 L: 2 K: 4 M: 0 F: 1 P: 2 S: 0 T: 1 W: 0 Y: 1 V: 2
Chemical Descriptors
24 reviewed residue count
C121H204N28O27S2 sequence-only estimate (linear, free termini)
2547.24 sequence-only estimate (linear, free termini)
9.98 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-1.06 sequence-only estimate (linear, free termini)
1.067 sequence-only estimate (linear, free termini)
Evidence Records 17 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1.17 µg/mL

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC
Evidence 2 Activity

Activity

MIC
Antibacterial
9.38 µg/mL

Target

Staphylococcus aureus ATCC43300

Source & Reference

dbAMP DRAMP

Other

Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 3 Activity

Activity

MIC
Antibacterial
2.34 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

ctive against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 4 Activity

Activity

MIC
Antifungal
1.17 µg/mL

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC
Evidence 5 Activity

Activity

MIC
Antifungal
9.38 µg/mL

Target

Staphylococcus aureus ATCC43300

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 6 Activity

Activity

MIC
Antifungal
2.34 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ctive against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 7 Activity

Activity

MIC
Antiparasitic
1.17 µg/mL

Target

Staphylococcus aureus ATCC25923

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC
Evidence 8 Activity

Activity

MIC
Antiparasitic
9.38 µg/mL

Target

Staphylococcus aureus ATCC43300

Source & Reference

DRAMP

Other

Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 9 Activity

Activity

MIC
Antiparasitic
2.34 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

ctive against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 10 Activity

Activity

MIC
Antiviral
1.17 µg/mL

Target

Staphylococcus aureus ATCC25923

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC
Evidence 11 Activity

Activity

MIC
Antiviral
9.38 µg/mL

Target

Staphylococcus aureus ATCC43300

Source & Reference

DRAMP

Other

Active against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 12 Activity

Activity

MIC
Antiviral
2.34 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

ctive against S. aureus ATCC25923 (MIC 1.17 ug/ml), S. aureus ATCC43300 (MIC 9.38 ug/ml), B. subtilis (MIC 2.34 ug/ml), and C. albicans ATCC2002 (2.34 ug/ml). Updated 7/2020
Evidence 13 Activity

Activity

% Hemolysis
Hemolysis
0.25 %
[Ref.19778602] It has 18.64 ± 0.25% hemolytic activity at 100 µg/ml against rabbit red blood cells

Target

rabbit red blood cells

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Genomics. 2010 Jan 95(1):66-71.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

19% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
19% Hemolysis | 100 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata | Genomics | 2010
Evidence 15 Activity

Activity

(45.99±0.36)% Degranulation
Toxicity
50 µg/mL
Cytotoxic
(45.99±0.36)% Degranulation | 50 | µg/mL | target cell: Rat mast cells

Target

Rat mast cells

Source & Reference

NA
DBAASP
Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata | Genomics | 2010
Evidence 16 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.19778602] It has 18.64 ± 0.25% hemolytic activity at 100 µg/ml against rabbit red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Genomics. 2010 Jan 95(1):66-71.
Evidence 17 Hemolysis

Activity

0.25 %
% Hemolysis
[Ref.19778602] It has 18.64 ± 0.25% hemolytic activity at 100 µg/ml against rabbit red blood cells
Hemolysis

Target

rabbit red blood cells

Source & Reference

APD_complete HemoPI PD_Hemolysis
Genomics. 2010 Jan 95(1):66-71.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.